ArticleJournal of contemporary brachytherapy2025
Efficacy of medial needles in mitigating dose deficits from sub-optimally inserted tandems in cervical interstitial brachytherapy.
Article in Journal of contemporary brachytherapy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- The value of pre-brachytherapy MRI in aiding applicator selection for cervical cancer procedures.Journal of contemporary brachytherapy · 2026Article
- Volume not the defining metric: Dosimetric benefits of adding supplemental interstitial needles for small volume cervical tumors.Journal of contemporary brachytherapy · 2026Article
- RE: Efficacy of medial needles in mitigating dose deficits from sub-optimally inserted tandems in cervical interstitial brachytherapy.Journal of contemporary brachytherapy · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: In cervical interstitial brachytherapy, sub-optimal tandem insertion can lead to inadequate dose coverage of clinical target volume (CTV). This study aimed to evaluate the effectiveness of medial interstitial needles in optimizing dose to CTV, while minimizing toxicity to organs at risk (OARs), such as bladder, rectum, and sigmoid colon. Material and methods: The study included 25 brachytherapy plans in seven subjects with locally advanced cervical cancer, who had sub-optimal tandem insertions during cervical interstitial brachytherapy, for which 1 or more medial needle was inserted Results: Compared with plans without medial needles (x̄ = 5.22 ±1.60 Gy, median = 5.68 Gy), the plans with medial needles activated (x̄ = 6.59 ±1.55 Gy, median = 7.08 Gy) achieved 26.2% and 24.6% improvement ( Conclusions: In patients with sub-optimal tandem insertion, the placement of medial needles can compensate dose deficit, while keeping OARs doses within acceptable constraints. Further studies among larger cohorts are warranted to optimize treatment protocol.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.